Zomedica Corp.
AMEX:ZOM
0.1671 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 25.186 | 18.93 | 4.133 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 7.868 | 5.278 | 1.079 | 0.53 | 0.788 | 0.206 | 0.092 | 0.046 | 0 | 0 | 0 |
| Gross Profit
| 17.318 | 13.652 | 3.054 | -0.53 | -0.788 | -0.206 | -0.092 | -0.046 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.688 | 0.721 | 0.739 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 5.744 | 2.578 | 1.673 | 8.044 | 10.345 | 10.317 | 2.751 | 1.519 | 0.758 | 0 | 0 |
| General & Administrative Expenses
| 29.029 | 22.934 | 0 | 7.929 | 8.18 | 5.83 | 5.076 | 4.24 | 1.427 | 0.042 | 0.077 |
| Selling & Marketing Expenses
| 14.137 | 9.879 | 0 | 0.262 | 0.472 | 0.226 | 0.164 | 0.194 | 0.143 | 0 | 0 |
| SG&A
| 43.166 | 32.997 | 22.749 | 8.191 | 8.651 | 6.056 | 5.24 | 4.434 | 1.57 | 0.042 | 0.077 |
| Other Expenses
| 0 | -0.007 | 0.006 | 0.53 | 0.788 | 0.206 | 0.092 | 0.046 | 0 | 0 | 0 |
| Operating Expenses
| 48.91 | 35.575 | 24.428 | 16.765 | 19.784 | 16.579 | 8.084 | 5.999 | 2.281 | 0.042 | 0.077 |
| Operating Income
| -31.592 | -21.923 | -21.374 | -16.765 | -19.784 | -16.579 | -8.084 | -5.999 | -2.288 | -0.042 | -0.077 |
| Operating Income Ratio
| -1.254 | -1.158 | -5.171 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -4.268 | 2.542 | 0.658 | -0.147 | 0 | -0.068 | 0.019 | 0.258 | 0.007 | 0 | 0 |
| Income Before Tax
| -35.86 | -19.381 | -20.716 | -16.912 | -19.784 | -16.648 | -8.065 | -6.013 | -2.281 | -0.042 | -0.077 |
| Income Before Tax Ratio
| -1.424 | -1.024 | -5.012 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -1.331 | -2.366 | -2.333 | 0.009 | 0.038 | 0.137 | -0.019 | 0.029 | 0 | 0 | 0 |
| Net Income
| -34.529 | -17.015 | -18.383 | -16.921 | -19.822 | -16.648 | -8.065 | -6.013 | -2.281 | -0.042 | -0.077 |
| Net Income Ratio
| -1.371 | -0.899 | -4.448 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.035 | -0.017 | -0.019 | -0.046 | -0.19 | -0.18 | -0.092 | -0.075 | -0.049 | -0.042 | -0.23 |
| EPS Diluted
| -0.035 | -0.017 | -0.019 | -0.046 | -0.19 | -0.18 | -0.092 | -0.075 | -0.049 | -0.042 | -0.23 |
| EBITDA
| -29.387 | -15.338 | -19.571 | -16.381 | -18.996 | -16.442 | -7.973 | -5.967 | -2.279 | -0.042 | -0.077 |
| EBITDA Ratio
| -1.167 | -0.81 | -4.74 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |